Women and Their Hormones – Diagnosing Abnormalities

Independent observation of one's own body should never replace professional medical consultation, yet it constitutes a fundamental component in the early detection of potential irregularities. The female reproductive system is equipped with a highly sophisticated signaling mechanism whose subtle fluctuations may indicate developing dysfunctions long before overt clinical symptoms manifest. Unfortunately, many patients either underestimate or misinterpret these signals, thereby delaying diagnosis. The menstrual cycle, as a cyclically recurring physiological process, serves as an exceptional tool for health monitoring—its regularity, the duration of individual phases, and the accompanying somatic and psychological symptoms provide invaluable insights into hormonal balance and overall bodily function. A thorough comprehension of the regulatory mechanisms governing this process, including the roles of key hormones (estrogen, progesterone, FSH, LH) and the distinctive features of each phase, not only facilitates the identification of deviations from normative patterns but also enables the implementation of appropriate preventive or therapeutic interventions in collaboration with healthcare specialists.

Women are frequently capable of recognizing subtle clinical indicators of hormonal imbalance that induce significant somatic and emotional distress: fluid retention, mood lability, reduced pain tolerance, diminished libido, pelvic discomfort, chronic fatigue, and cycle irregularities. The predominant driver of cyclical fluid retention is relative estrogen dominance during the luteal phase, coupled with hypothalamic vasopressin dysregulation. Conversely, severe menorrhagia accompanied by dysmenorrhea frequently points toward endometriosis, uterine leiomyomas, or profound progestogenic insufficiency. Chronic lethargy, decreased libido, and unexplained weight gain commonly stem from hypothyroidism or Hashimoto's autoimmune thyroiditis—necessitating comprehensive laboratory evaluation of TSH, free T3, free T4, and anti-TPO/anti-TG antibodies. Another prevalent endocrine disorder is Polycystic Ovary Syndrome (PCOS), characterized by clinical or biochemical hyperandrogenism, insulin resistance, anovulatory oligomenorrhea, and polycystic ovarian morphology on transvaginal ultrasonography. When investigating secondary amenorrhea, evaluating the hypothalamic-pituitary-ovarian axis via serum FSH, LH, estradiol, progesterone, and prolactin is paramount. Stress-induced hypercortisolemia further suppresses thyroid hormone peripheral deiodination and downregulates ovarian steroidogenesis. Any persistent symptoms necessitate thorough gynecological and endocrinological consultation.